Logo image of PHA.CA

PREMIER HEALTH OF AMERICA IN (PHA.CA) Stock Fundamental Analysis

TSX-V:PHA - TSX Venture Exchange - CA74052G1063 - Common Stock - Currency: CAD

0.065  -0.01 (-13.33%)

Fundamental Rating

2

Overall PHA gets a fundamental rating of 2 out of 10. We evaluated PHA against 16 industry peers in the Health Care Providers & Services industry. PHA may be in some trouble as it scores bad on both profitability and health. PHA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year PHA has reported negative net income.
PHA had a positive operating cash flow in the past year.
In multiple years PHA reported negative net income over the last 5 years.
Of the past 5 years PHA 4 years had a positive operating cash flow.
PHA.CA Yearly Net Income VS EBIT VS OCF VS FCFPHA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -25.76%, PHA is doing worse than 68.75% of the companies in the same industry.
Industry RankSector Rank
ROA -25.76%
ROE N/A
ROIC N/A
ROA(3y)-6.71%
ROA(5y)-3.2%
ROE(3y)-105.76%
ROE(5y)-61.59%
ROIC(3y)N/A
ROIC(5y)N/A
PHA.CA Yearly ROA, ROE, ROICPHA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

The Gross Margin of PHA (15.92%) is worse than 75.00% of its industry peers.
PHA's Gross Margin has declined in the last couple of years.
PHA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 15.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.25%
GM growth 5Y-4.32%
PHA.CA Yearly Profit, Operating, Gross MarginsPHA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

2

2. Health

2.1 Basic Checks

PHA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PHA has more shares outstanding
PHA has more shares outstanding than it did 5 years ago.
PHA has a worse debt/assets ratio than last year.
PHA.CA Yearly Shares OutstandingPHA.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
PHA.CA Yearly Total Debt VS Total AssetsPHA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

PHA has an Altman-Z score of 0.98. This is a bad value and indicates that PHA is not financially healthy and even has some risk of bankruptcy.
PHA's Altman-Z score of 0.98 is in line compared to the rest of the industry. PHA outperforms 50.00% of its industry peers.
The Debt to FCF ratio of PHA is 44.99, which is on the high side as it means it would take PHA, 44.99 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 44.99, PHA is doing good in the industry, outperforming 62.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 44.99
Altman-Z 0.98
ROIC/WACCN/A
WACC10.16%
PHA.CA Yearly LT Debt VS Equity VS FCFPHA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M 25M

2.3 Liquidity

PHA has a Current Ratio of 0.54. This is a bad value and indicates that PHA is not financially healthy enough and could expect problems in meeting its short term obligations.
PHA's Current ratio of 0.54 is in line compared to the rest of the industry. PHA outperforms 43.75% of its industry peers.
A Quick Ratio of 0.54 indicates that PHA may have some problems paying its short term obligations.
PHA has a Quick ratio (0.54) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 0.54
Quick Ratio 0.54
PHA.CA Yearly Current Assets VS Current LiabilitesPHA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

3

3. Growth

3.1 Past

PHA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -410.90%.
PHA shows a small growth in Revenue. In the last year, the Revenue has grown by 3.02%.
The Revenue has been growing by 68.58% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-410.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.8%
Revenue 1Y (TTM)3.02%
Revenue growth 3Y33.41%
Revenue growth 5Y68.58%
Sales Q2Q%-41.36%

3.2 Future

Based on estimates for the next years, PHA will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.79% on average per year.
PHA is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.61% yearly.
EPS Next Y40.21%
EPS Next 2Y18.19%
EPS Next 3Y11.79%
EPS Next 5YN/A
Revenue Next Year-20.72%
Revenue Next 2Y-10.85%
Revenue Next 3Y-5.61%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PHA.CA Yearly Revenue VS EstimatesPHA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
PHA.CA Yearly EPS VS EstimatesPHA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 -0.1 -0.15

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PHA. In the last year negative earnings were reported.
Also next year PHA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PHA.CA Price Earnings VS Forward Price EarningsPHA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

PHA's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, PHA is valued cheaper than 93.75% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.46
EV/EBITDA 60.56
PHA.CA Per share dataPHA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.19%
EPS Next 3Y11.79%

More info and screens

0

5. Dividend

5.1 Amount

PHA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PREMIER HEALTH OF AMERICA IN

TSX-V:PHA (6/2/2025, 7:00:00 PM)

0.065

-0.01 (-13.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-21 2025-05-21
Earnings (Next)08-19 2025-08-19
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners46.21%
Ins Owner ChangeN/A
Market Cap3.61M
Analysts40
Price Target0.2 (207.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-33.94%
Min Revenue beat(2)-39.96%
Max Revenue beat(2)-27.91%
Revenue beat(4)0
Avg Revenue beat(4)-26.47%
Min Revenue beat(4)-39.96%
Max Revenue beat(4)-14.13%
Revenue beat(8)2
Avg Revenue beat(8)-12.94%
Revenue beat(12)2
Avg Revenue beat(12)-9.89%
Revenue beat(16)6
Avg Revenue beat(16)-0.2%
PT rev (1m)0%
PT rev (3m)-60%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-404.35%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-12.93%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF 3.46
P/OCF 0.95
P/B N/A
P/tB N/A
EV/EBITDA 60.56
EPS(TTM)-0.29
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)0.02
FCFY28.93%
OCF(TTM)0.07
OCFY105.04%
SpS2.42
BVpS-0.02
TBVpS-0.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.76%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 15.92%
FCFM 0.78%
ROA(3y)-6.71%
ROA(5y)-3.2%
ROE(3y)-105.76%
ROE(5y)-61.59%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.25%
GM growth 5Y-4.32%
F-Score4
Asset Turnover2.14
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 44.99
Debt/EBITDA 0.18
Cap/Depr 37.93%
Cap/Sales 2.05%
Interest Coverage N/A
Cash Conversion 474.34%
Profit Quality N/A
Current Ratio 0.54
Quick Ratio 0.54
Altman-Z 0.98
F-Score4
WACC10.16%
ROIC/WACCN/A
Cap/Depr(3y)35.11%
Cap/Depr(5y)76.64%
Cap/Sales(3y)1.6%
Cap/Sales(5y)1.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-410.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-105.8%
EPS Next Y40.21%
EPS Next 2Y18.19%
EPS Next 3Y11.79%
EPS Next 5YN/A
Revenue 1Y (TTM)3.02%
Revenue growth 3Y33.41%
Revenue growth 5Y68.58%
Sales Q2Q%-41.36%
Revenue Next Year-20.72%
Revenue Next 2Y-10.85%
Revenue Next 3Y-5.61%
Revenue Next 5YN/A
EBIT growth 1Y-259.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-41.28%
EBIT Next 3Y-11.94%
EBIT Next 5YN/A
FCF growth 1Y114.9%
FCF growth 3Y400.47%
FCF growth 5Y56.2%
OCF growth 1Y165.89%
OCF growth 3Y44.26%
OCF growth 5Y70.26%